Who it's for
The category: Evidence-based imaging CDS + CMS-0057-F prior-auth readiness layer; Non-Device CDS, no FDA 510(k)
Buyer map
Six seats on every hospital imaging deal: clinical owner, finance sponsor, daily champion, end user, regulatory clock, and the cost of waiting.
Primary buyer
Who
Provider: Radiology CMIO / Chief of Radiology (clinical owner) partnered with VP Revenue Cycle. Payer / risk: VP of Utilization Management / Payer Medical Director
Cares about
Order appropriateness, denial rate on imaging, clean-claim rate, clinician friction; auto-approval rate, review cost, turnaround-time compliance, gold-carding
Economic buyer
Who
CFO / VP of Finance — owns net patient revenue and the denial write-off line
Cares about
Recovered revenue, cost-to-collect, payback period, OpEx vs. CapEx
Champion (feels the pain daily)
Who
Denials / Revenue-Cycle Director and the Radiology CMIO whose orders bounce; on the payer side, the UM nurse lead drowning in manual reviews
Cares about
"Make the rework stop"; "stop making me click"
User
Who
Ordering clinician (in-flow CDS card in Epic/Cerner/Athena), UM reviewer (reviewer dashboard), rev-cycle analyst (validation/ROI dashboards)
Cares about
Zero added clicks; silent unless a guideline fires
Urgency trigger (why now)
Who
CMS-0057-F: faster decisions + specific denial reason enforced through 2026, and four FHIR APIs (incl. Da Vinci PAS) by Jan 1, 2027. Denials are rising (11.8% initial, 2024, and climbing; advanced imaging 25–40%). And CMS rescinded the AUC/PAMA imaging-appropriateness mandate in 2024 — leaving a governance vacuum that prior-auth denials now fill.
Cares about
The compliance clock + the denial curve both point up and to the right
ROI case (what if they don't act)
Who
Keep writing off ~$3.5M+/yr in avoidable imaging denials (~65% never reworked; rework costs $25–$118/claim); arrive at the 2027 API deadline unprepared; let Optum/Carelon-style payer UM keep tightening imaging PA against them
Cares about
The status quo is a standing, compounding write-off
Take it with you
Download the one-page PDF for internal enablement — or use vendor-neutral evaluation criteria and the resource center for ROI, implementation, and compliance handouts.
Who it's for
The category: Evidence-based imaging CDS + CMS-0057-F prior-auth readiness layer; Non-Device CDS, no FDA 510(k)
Buyer map
Six seats on every hospital imaging deal: clinical owner, finance sponsor, daily champion, end user, regulatory clock, and the cost of waiting.
Primary buyer
Who
Provider: Radiology CMIO / Chief of Radiology (clinical owner) partnered with VP Revenue Cycle. Payer / risk: VP of Utilization Management / Payer Medical Director
Cares about
Order appropriateness, denial rate on imaging, clean-claim rate, clinician friction; auto-approval rate, review cost, turnaround-time compliance, gold-carding
Economic buyer
Who
CFO / VP of Finance — owns net patient revenue and the denial write-off line
Cares about
Recovered revenue, cost-to-collect, payback period, OpEx vs. CapEx
Champion (feels the pain daily)
Who
Denials / Revenue-Cycle Director and the Radiology CMIO whose orders bounce; on the payer side, the UM nurse lead drowning in manual reviews
Cares about
"Make the rework stop"; "stop making me click"
User
Who
Ordering clinician (in-flow CDS card in Epic/Cerner/Athena), UM reviewer (reviewer dashboard), rev-cycle analyst (validation/ROI dashboards)
Cares about
Zero added clicks; silent unless a guideline fires
Urgency trigger (why now)
Who
CMS-0057-F: faster decisions + specific denial reason enforced through 2026, and four FHIR APIs (incl. Da Vinci PAS) by Jan 1, 2027. Denials are rising (11.8% initial, 2024, and climbing; advanced imaging 25–40%). And CMS rescinded the AUC/PAMA imaging-appropriateness mandate in 2024 — leaving a governance vacuum that prior-auth denials now fill.
Cares about
The compliance clock + the denial curve both point up and to the right
ROI case (what if they don't act)
Who
Keep writing off ~$3.5M+/yr in avoidable imaging denials (~65% never reworked; rework costs $25–$118/claim); arrive at the 2027 API deadline unprepared; let Optum/Carelon-style payer UM keep tightening imaging PA against them
Cares about
The status quo is a standing, compounding write-off
Take it with you
Download the one-page PDF for internal enablement — or use vendor-neutral evaluation criteria and the resource center for ROI, implementation, and compliance handouts.